Empirico Inc.

Industry

  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
      • Bioinformatics
      • Genomics-Proteomics
See more in Biomedtracker

Latest on Empirico Inc.

Scrip

Deal Watch: Novo Nordisk Links With Flagship To Create Cardiometabolic, Rare Disease Portfolio

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novo Nordisk, Flagship Hope Combined Ef

Scrip

Deal Watch: Gain To Test Enzyme-Enhancement Tech In Cancer With Zentalis

 
• By Joseph Haas and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gain, Zentalis Hope To Find Protein Mis

Scrip

Finance Watch: 2020 Cell And Gene Therapy Funding Already Bests 2019

 
• By Mandy Jackson

Cell and gene therapy companies raised $10.7bn during the first half of 2020, exceeding the $9.8bn full-year total that the regenerative medicine sector raised in 2019. Venture capital financings in t